TerminatedPhase 1NCT03239470
Polyclonal Regulatory T Cells (PolyTregs) for Pemphigus
Studying Pemphigus foliaceus
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Principal Investigator
- Haley Naik, MD,MHScUniversity of California San Francisco School of Medicine: Department of Dermatology
- Intervention
- Cohort 1: 1.0 x 10^8 PolyTregs(biological)
- Enrollment
- 5 enrolled
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2017 – 2023
Study locations (4)
- University of California San Francisco School of Medicine: Department of Dermatology, San Francisco, California, United States
- University of Iowa Health Care: Department of Dermatology, Iowa City, Iowa, United States
- Duke University Medical Center: Department of Dermatology, Durham, North Carolina, United States
- University of Texas Southwestern Medical Center: Department of Dermatology, Dallas, Texas, United States
Collaborators
Autoimmunity Centers of Excellence · Rho Federal Systems Division, Inc.
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03239470 on ClinicalTrials.gov